Randall Pellish to Remission Induction
This is a "connection" page, showing publications Randall Pellish has written about Remission Induction.
Connection Strength
0.059
-
Stein BN, Pellish RS, Thompson KD, Baptista V, Siegel CA. Using Therapeutic Drug Monitoring to Identify Variable Infliximab Metabolism in an Individual Patient With Ulcerative Colitis. J Clin Gastroenterol. 2016 Jan; 50(1):66-8.
Score: 0.032
-
Juillerat P, Wasan SK, Fowler SA, Friedman S, Pabby VK, Coukas JA, Barto AE, Pellish R, Germansky KA, Cheifetz AS, Korzenik JR, Farraye FA, Yajnik V. Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. Inflamm Bowel Dis. 2013 Oct; 19(11):2457-63.
Score: 0.027